Braskem Balanced Scorecard

Braskem Balanced Scorecard

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Braskem Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Unlock the Full Balanced Scorecard for Deeper Strategic Insight

This Braskem Balanced Scorecard Analysis gives you a structured view of the company's financial, customer, internal process, and learning and growth priorities. The page already shows a real preview of the actual analysis, so you can review the content before buying. Purchase the full version to get the complete ready-to-use report.

Benefits

Icon

Sustainability Goal Alignment

Braskem's Balanced Scorecard ties sustainability to delivery by tracking its 1 million tons of green PE capacity target for 2030. It turns ESG goals into KPI metrics, like carbon reduction per ton produced, so managers can track progress month by month through March 2026. This link matters because green polymer output and emissions intensity now shape capital spend, margin mix, and customer demand.

Icon

Operational Process Efficiency

Operational process efficiency at Braskem depends on tracking feedstock flexibility, so the company can switch between naphtha and gas when price spreads move. In 2025, this mattered because variable feedstock costs directly affected manufacturing spreads across Braskem's U.S. and European chemical assets. The scorecard should tie this to lower unit costs, faster switching, and better margin protection.

Explore a Preview
Icon

Customer Retention Strategies

In Braskem's 2025 balanced scorecard, tracking Net Promoter Score by specialty polymer segment helps spot which medical and automotive customers value performance most. That feedback can steer R&D into higher-margin uses, since specialty grades usually earn better pricing than commodity PE and PP. A tighter retention loop also lowers churn and supports repeat orders in 2025.

Icon

Workforce Innovation Velocity

Workforce Innovation Velocity in Braskem's Learning and Growth perspective tracks patent applications and renewable-chemistry certifications to keep its global workforce of over 8,000 ready for the 2026 bio-circular economy. More filings signal faster idea capture, while more certified staff means quicker scale-up of low-carbon products and processes. This lifts execution speed, supports innovation-led margins, and keeps skills aligned with market shifts.

Icon

Improved Capital Allocation

Improved capital allocation in Braskem Balanced Scorecard Analysis ties every new Capex project to a long-term ROIC target above 12%, so spending has to clear a clear return hurdle. That matters after large global production expansion cycles, because disciplined project screening helps keep debt under control and avoids low-return capacity adds. In 2025, this links growth to cash discipline, which is the fastest way to protect balance sheet strength and raise capital efficiency.

Icon

Braskem's 2025 KPIs Tie ESG, Cost Control, and Growth Together

Braskem's scorecard benefits are clearer in 2025: it links sustainability, cost control, and growth to one set of KPIs. That helps protect margins as feedstock swings hit its global asset base and as low-carbon products support demand.

Benefit 2025 KPI
ESG execution 1m t green PE by 2030
Talent 8,000+ staff
Capital discipline ROIC >12%

What is included in the product

Word Icon Detailed Word Document
Maps out how Braskem connects financial results with customer, process, and capability-building priorities
Plus Icon
Excel Icon Editable Excel File
Provides a quick Balanced Scorecard view of Braskem to pinpoint performance gaps and simplify strategic decision-making.

Drawbacks

Icon

High Administrative Overhead

Running a Balanced Scorecard across 40 manufacturing plants creates heavy admin work, because leaders must standardize metrics, audit plant data, and keep reporting aligned. In Braskem, that can pull executive time away from fast moves in global thermoplastic prices, where margins can shift in days. The bigger the scorecard, the more it can slow response time in 2025 when price and demand signals stay volatile.

Icon

Historical Data Dependency

Braskem's scorecard leans on 2025 lagging metrics like revenue, EBITDA, and cash flow, so it shows what already happened, not what is changing now. That can delay action when petrochemical spreads or feedstock costs swing sharply in early 2026. If the cycle turns fast, a 2025-only view can miss the first hit to margins and working capital.

Explore a Preview
Icon

Regional Data Inconsistency

Regional Data Inconsistency makes Braskem's scorecard harder to trust because Brazil and US units report under different local rules, timelines, and cost bases. In 2025, Braskem still had operations split across major markets, so a single efficiency score can mask site-level swings in utilization, margins, and working capital. When accounting standards differ, even small FX or inventory timing gaps can distort a unified operating view.

Icon

Limited Qualitative Depth

Braskem's balanced scorecard can miss the softer signals that matter after environmental events, because numbers do not fully show changes in trust or brand sentiment. A 2025 metric can show output or cost trends, but it may still hide how residents, regulators, and customers feel about the Company Name.

That gap matters when stakeholder relations drive permits, sales, and litigation risk. Hard data can track incidents and cash costs, but it cannot capture whether local communities now see Company Name as credible or distant.

Icon

Inflexible Strategic Rigidity

Braskem's fixed 2026 Balanced Scorecard milestones can lock teams into preset actions, which slows responses if rival producers shift pricing or capacity. That rigidity is risky in recycled polymers, where fast M&A can matter more than hitting a static KPI on time. Over-committing to one target path can make Braskem miss small, fast deals that secure feedstock, tech, or market share.

Icon

Braskem's 2025 Scorecard: Useful, but Slow on Fast-Moving Risks

Braskem's 2025 Balanced Scorecard is useful, but it also adds admin load across 40 plants, so leaders spend more time standardizing data than reacting to price swings. It relies on lagging EBITDA, cash flow, and revenue, so it can miss fast margin hits. Regional reporting gaps and fixed 2026 targets can also hide local shocks and slow moves.

Drawback 2025 signal Risk
Admin load 40 plants Slower response
Lagging KPIs EBITDA, cash flow Late action

What You See Is What You Get
Braskem Reference Sources

This preview shows the actual Braskem Balanced Scorecard Analysis document you'll receive after purchase – no sample, no filler. What you see here is taken directly from the final report, so the full version matches this layout and content. Once purchased, you'll unlock the complete, detailed analysis in the same professional format.

Explore a Preview

Frequently Asked Questions

The BSC demonstrates a commitment to disciplined growth and ESG integration, key for institutional investors in 2026. By tracking a debt-to-EBITDA ratio target below 2.5x alongside 1,000,000 tons of bio-polymer capacity, the scorecard provides proof of fiscal and environmental viability. Investors gain transparency into whether the company's $1.5 billion innovation budget is effectively driving circular economy revenues.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.